This ticker has not been starred yet CRNX Crinetics Pharmaceuticals, Inc.
Pharmaceutical Preparations
Book value per $ invested $ 0.42
Leverage 11.91%
Market Cap $ 2.4B
PE 0.00
Dividend Yield 0.00%
Profit $ -463.5m
Margin -5812.28%

Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapies for rare endocrine diseases and endocrine-related tumors. The company is headquartered in San Diego, California.

Subscribe Now For Access - Only $1.99 Per Month